Loading insider details...
Beta
Latest Form 4 (May 1, 2026): Grant/Award of 48,800 ALT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 1, 2026 | Altimmune, Inc. (ALT) | Grant/Award | 48,800 | n/a |
| Dec 29, 2025 | Altimmune, Inc. (ALT) | Purchase | 527 | $2.0K |
| Sep 29, 2025 | Altimmune, Inc. (ALT) | Grant/Award | 48,800 | n/a |
| Sep 30, 2024 | Altimmune, Inc. (ALT) | Grant/Award | 34,900 | n/a |
| Sep 29, 2023 | Altimmune, Inc. (ALT) | Grant/Award | 26,100 | n/a |
| Oct 1, 2022 | Altimmune, Inc. (ALT) | Grant/Award | 23,500 | n/a |
| Jun 28, 2022 | Altimmune, Inc. (ALT) | Exercise/Conversion | 17,610 | $55.5K |
| Oct 1, 2021 | Altimmune, Inc. (ALT) | Grant/Award | 24,100 | n/a |
| Sep 28, 2020 | Altimmune, Inc. (ALT) | Grant/Award | 9,500 | n/a |
| May 12, 2020 | Altimmune, Inc. (ALT) | Grant/Award | 40,000 | n/a |